XTX301 in Patients With Advanced Solid Tumors
XTX301 in Patients With Advanced Solid Tumors
Recruiting · NCT05684965 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| XTX301 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-23 | NCT05684965 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xilio Development, Inc. | 3 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hackensack University Medical Center | Hackensack | United States | 308 |
| HealthPartners Frauenshuh Cancer Center | Saint Louis Park | United States | 4 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| Sheboygan Cancer & Blood Specialists | Sheboygan | United States | 3 |
| The Gabrail Pharmacology Phase 1 Research Center | Canton | United States | 1 |
| The Ohio State University Wexner Medical Center | Columbus | United States | 6 |
| Tranquil Clinical Research | Webster | United States | 11 |
| University Hospital Cleveland Medical Center | Cleveland | United States | 6 |
| University of California, Davis Comprehensive Cancer Center | Sacramento | United States | 18 |
| University of Pittsburgh Medical Center-Hillman Cancer Center | Pittsburgh | United States | 2 |
| Washington University School of Medicine | St Louis | United States | 895 |
| Yale Cancer Center | New Haven | United States | 42 |